The ceramide system as a novel antidepressant target

Trends in Pharmacological Sciences

Volumn 35, Issue 6, 2014, Pages 293-304

  Kornhuber, Johannes ^a   Müller, Christian P ^a   Becker, Katrin Anne ^b   Reichel, Martin ^a   Gulbins, Erich ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

acid sphingomyelinase; ceramide; depression; inflammation; neurogenesis; stress

Indexed keywords

ANTIDEPRESSANT AGENT; CERAMIDE; CYTOKINE; MONOAMINE;

CLINICAL FEATURE; CYTOKINE RESPONSE; DEPRESSION; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG TARGETING; EXPERIMENTAL MOUSE; HUMAN; LIFESTYLE; LIPID METABOLISM; LIPOGENESIS; MENTAL STRESS; NERVE CELL PLASTICITY; NEUROBIOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PSYCHOPHARMACOTHERAPY; REVIEW; SIGNAL TRANSDUCTION;

ACID SPHINGOMYELINASE; CERAMIDE; DEPRESSION; INFLAMMATION; NEUROGENESIS; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CERAMIDES; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84901774687     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.04.003     Document Type: Review

References (124)

1. J. Alonso et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project Acta Psychiatr. Scand. Suppl. 420 2004 21 27
2. F. Lamers et al. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA) J. Clin. Psychiatry 71 2010 1582 1589
3. F. Lamers et al. Structure of major depressive disorder in adolescents and adults in the US general population Br. J. Psychiatry 201 2012 143 150
4. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 e442
5. R.W. Maris Suicide Lancet 360 2002 319 326 (Pubitemid 34874728)
6. P.F. Sullivan et al. Genetic epidemiology of major depression: review and meta-analysis Am. J. Psychiatry 157 2000 1552 1562
7. S. Ripke et al. A mega-analysis of genome-wide association studies for major depressive disorder Mol. Psychiatry 18 2013 497 511
8. M.J. Kempton et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder Arch. Gen. Psychiatry 68 2011 675 690
9. R.S. Duman et al. A molecular and cellular theory of depression Arch. Gen. Psychiatry 54 1997 597 606 (Pubitemid 27306570)
10. K.L. Spalding et al. Dynamics of hippocampal neurogenesis in adult humans Cell 153 2013 1219 1227
11. D.T. Balu, and I. Lucki Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology Neurosci. Biobehav. Rev. 33 2009 232 252
12. J.S. Snyder et al. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour Nature 476 2011 458 461
13. L. Santarelli et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809 (Pubitemid 36962615)
14. N. Risch et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis JAMA 301 2009 2462 2471
15. K.S. Kendler et al. Causal relationship between stressful life events and the onset of major depression Am. J. Psychiatry 156 1999 837 841 (Pubitemid 29260336)
16. A. Caspi et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389 (Pubitemid 36877077)
17. R.M. Sapolsky et al. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis Endocr. Rev. 7 1986 284 301
18. C. Louis et al. Antidepressant-like effects of the corticotropin- releasing factor 1 receptor antagonist, SSR 125543, and the vasopressin 1b receptor antagonist, SSR 149415, in a DRL-72 s schedule in the rat Neuropsychopharmacology 31 2006 2180 2187 (Pubitemid 44413195)
19. M. Maes, and H.Y. Meltzer The serotonin hypothesis of depression F.E. Bloom, D.J. Kupfer, Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press 933 944
20. A. Serretti et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients Mol. Psychiatry 12 2007 247 257 (Pubitemid 46328503)
21. H.G. Ruhé et al. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies Mol. Psychiatry 12 2007 331 359 (Pubitemid 46496835)
22. I. Mahar et al. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects Neurosci. Biobehav. Rev. 38 2014 173 192
23. Y. Dowlati et al. A meta-analysis of cytokines in major depression Biol. Psychiatry 67 2010 446 457
24. Y. Liu et al. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression J. Affect. Disord. 139 2012 230 239
25. A. Reichenberg et al. Cytokine-associated emotional and cognitive disturbances in humans Arch. Gen. Psychiatry 58 2001 445 452 (Pubitemid 32411324)
26. B.D. Karrenbauer et al. Time-dependent in-vivo effects of interleukin-2 on neurotransmitters in various cortices: relationships with depressive-related and anxiety-like behaviour J. Neuroimmunol. 237 2011 23 32
27. B.W.J.H. Penninx et al. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile BMC Med. 11 2013 129
28. S. Lahiri, and A.H. Futerman The metabolism and function of sphingolipids and glycosphingolipids Cell. Mol. Life Sci. 64 2007 2270 2284 (Pubitemid 47347954)
29. H. Grassmé et al. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells Cell 91 1997 605 615 (Pubitemid 27513652)
30. S. Falcone et al. Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells J. Immunol. 173 2004 4452 4463 (Pubitemid 39280675)
31. A.Y. Zhang et al. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells Antioxid. Redox Signal. 9 2007 817 828
32. S. Mathias et al. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β Science 259 1993 519 522 (Pubitemid 23058710)
33. R. Göggel et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide Nat. Med. 10 2004 155 160
34. H. Grassmé et al. CD95 signaling via ceramide-rich membrane rafts J. Biol. Chem. 276 2001 20589 20596
35. M. Irie et al. Depressive state relates to female oxidative DNA damage via neutrophil activation Biochem. Biophys. Res. Commun. 311 2003 1014 1018 (Pubitemid 37393420)
36. K. Aschbacher et al. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity Psychoneuroendocrinology 38 2013 1698 1708
37. C.B. Wilson et al. Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model PLoS ONE 8 2013 e76146
38. S. Schiavone et al. NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology Transl. Psychiatry 2 2012 e111
39. Y. Zhang et al. Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis J. Immunol. 181 2008 4247 4254
40. X. Li et al. Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase Cell. Physiol. Biochem. 30 2012 815 826
41. H. Qiu et al. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine J. Biol. Chem. 278 2003 32744 32752 (Pubitemid 37055714)
42. Y.H. Zeidan, and Y.A. Hannun Activation of acid sphingomyelinase by protein kinase Cδ-mediated phosphorylation J. Biol. Chem. 282 2007 11549 11561 (Pubitemid 47100781)
43. A.G. Roth et al. Potent inhibition of acid sphingomyelinase by phosphoinositide analogues Chembiochem 10 2009 2367 2374
44. J. Kornhuber et al. High activity of acid sphingomyelinase in major depression J. Neural Transm. 112 2005 1583 1590 (Pubitemid 41504272)
45. H. Grassmé et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts Nat. Med. 9 2003 322 330 (Pubitemid 36362788)
46. O. Utermöhlen et al. Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase J. Immunol. 170 2003 2621 2628 (Pubitemid 36245654)
47. H. Grassmé et al. Ceramide-mediated clustering is required for CD95-DISC formation Oncogene 22 2003 5457 5470 (Pubitemid 37072201)
48. F. Bianco et al. Acid sphingomyelinase activity triggers microparticle release from glial cells EMBO J. 28 2009 1043 1054
49. J.A. Ciesla, and J.E. Roberts Meta-analysis of the relationship between HIV infection and risk for depressive disorders Am. J. Psychiatry 158 2001 725 730 (Pubitemid 32429839)
50. V. Teichgräber et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis Nat. Med. 14 2008 382 391 (Pubitemid 351499396)
51. A.M. Alayoubi et al. Systemic ceramide accumulation leads to severe and varied pathological consequences EMBO Mol. Med. 5 2013 827 842
52. S. Spiegel Sphingosine 1-phosphate: a prototype of a new class of second messengers J. Leukoc. Biol. 65 1999 341 344 (Pubitemid 29109706)
53. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat. Rev. Mol. Cell Biol. 9 2008 139 150 (Pubitemid 351158911)
54. N.A. Babenko, and E.G. Shakhova Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain Arch. Gerontol. Geriatr. 58 2014 420 426
55. G. Cizza et al. Depression and osteoporosis: a research synthesis with meta-analysis Horm. Metab. Res. 42 2010 467 482
56. B. Edelmann et al. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes EMBO J. 30 2011 379 394
57. A. Demirkan et al. Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study J. Psychiatr. Res. 47 2013 357 362
58. P. Gracia-Garcia et al. Elevated plasma ceramides in depression J. Neuropsychiatry Clin. Neurosci. 23 2011 215 218
59. M.M. Mielke et al. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study PLoS ONE 8 2013 e73094
60. E. Gulbins et al. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs Nat. Med. 19 2013 934 938
61. R.G. Cutler, and M.P. Mattson Sphingomyelin and ceramide as regulators of development and lifespan Mech. Ageing Dev. 122 2001 895 908 (Pubitemid 32441613)
62. C. Pavoine, and F. Pecker Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology Cardiovasc. Res. 82 2009 175 183
63. W. Doehner et al. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow Eur. Heart J. 28 2007 821 828 (Pubitemid 47343591)
64. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
65. S.M. de la Monte et al. Ceramide-mediated insulin resistance and impairment of cognitive-motor functions J. Alzheimers Dis. 21 2010 967 984
66. L.J.A. Spijkers et al. Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide PLoS ONE 6 2011 e21817
67. B.M. Altura et al. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: insight into mechanisms and possible relation to brain injury and stroke Brain Res. Bull. 58 2002 271 278 (Pubitemid 34786458)
68. M.O.W. Grimm et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin Nat. Cell Biol. 7 2005 1118 1123
69. R.G. Cutler et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 101 2004 2070 2075 (Pubitemid 38229016)
70. F. Samad et al. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk Diabetes 55 2006 2579 2587 (Pubitemid 44871159)
71. M. Shimabukuro et al. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes Proc. Natl. Acad. Sci. U.S.A. 95 1998 2498 2502 (Pubitemid 28145970)
72. H. Anisman et al. Cytokines as a stressor: implications for depressive illness Int. J. Neuropsychopharmacol. 5 2002 357 373 (Pubitemid 35470356)
73. A. Pan et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies Diabetes Care 35 2012 1171 1180
74. C. Mühle et al. Sphingolipids in psychiatric disorders and pain syndromes E. Gulbins, I. Petrache, Sphingolipids in Disease 2013 Springer 431 456
75. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
76. W. Zundel, and A. Giaccia Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress Genes Dev. 12 1998 1941 1946 (Pubitemid 28323868)
77. C. Luberto et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase J. Biol. Chem. 277 2002 41128 41139 (Pubitemid 35215704)
78. D. Wheeler et al. Tumor necrosis factor-α-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors J. Neurochem. 109 2009 1237 1249
79. E. Norman et al. Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms J. Neurochem. 114 2010 430 439
80. Z. Nahas et al. Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats Behav. Brain Res. 197 2009 41 44
81. L. Zhao et al. A deficiency of ceramide biosynthesis causes cerebellar Purkinje cell neurodegeneration and lipofuscin accumulation PLoS Genet. 7 2011 e1002063
82. C. Ginkel et al. Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes J. Biol. Chem. 287 2012 41888 41902
83. P. Ebel et al. Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities J. Biol. Chem. 288 2013 21433 21447
84. S.N. Yang Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: an essential role of postsynaptic protein phosphatases Neuroscience 96 2000 253 258
85. H. Schulze et al. Principles of lysosomal membrane degradation. Cellular topology and biochemistry of lysosomal lipid degradation Biochim. Biophys. Acta 1793 2009 674 683
86. C. de Duve et al. Lysosomotropic agents Biochem. Pharmacol. 23 1974 2495 2531
87. S. Trapp et al. Quantitative modeling of selective lysosomal targeting for drug design Eur. Biophys. J. 37 2008 1317 1328
88. M. Kölzer et al. Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine FEBS Lett. 559 2004 96 98 (Pubitemid 38186710)
89. R. Hurwitz et al. The tricyclic antidepressants desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts Biol. Chem. 375 1994 447 450 (Pubitemid 2120332)
90. J. Kornhuber et al. Functional inhibitors of acid sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications Cell. Physiol. Biochem. 26 2010 9 20
91. J. Kornhuber et al. Identification of novel functional inhibitors of acid sphingomyelinase PLoS ONE 6 2011 e23852
92. J. Kornhuber et al. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model J. Med. Chem. 51 2008 219 237
93. S. Albouz et al. Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines Life Sci. 38 1986 357 363 (Pubitemid 16169524)
94. W.L. Holland et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance Cell Metab. 5 2007 167 179
95. Z. Ye et al. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials PLoS ONE 6 2011 e21551
96. S.A. Hiles et al. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis Psychol. Med. 42 2012 2015 2026
97. J. Hannestad et al. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis Neuropsychopharmacology 36 2011 2452 2459
98. S.E. Kimmel et al. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression Br. J. Clin. Pharmacol. 72 2011 514 517
99. H. Vesper et al. Sphingolipids in food and the emerging importance of sphingolipids to nutrition J. Nutr. 129 1999 1239 1250 (Pubitemid 29304970)
100. C.A. Jolly et al. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide J. Nutr. 127 1997 37 43 (Pubitemid 27069013)
101. I.R. Lanza et al. Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet Am. J. Physiol. Endocrinol. Metab. 304 2013 E1391 E1403
102. N.A. Babenko, and Y.A. Semenova Effects of long-term fish oil-enriched diet on the sphingolipid metabolism in brain of old rats Exp. Gerontol. 45 2010 375 380
103. M. Lankinen et al. Fatty fish intake decreases lipids related to inflammation and insulin signaling - a lipidomics approach PLoS ONE 4 2009 e5258
104. I. Torre-Villalvazo et al. Dietary soy protein reduces cardiac lipid accumulation and the ceramide concentration in high-fat diet-fed rats and ob/ob mice J. Nutr. 139 2009 2237 2243
105. M.L. Borg et al. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice J. Physiol. 590 2012 4377 4389
106. S. Tsalouhidou et al. Effect of chronic exercise on DNA fragmentation and on lipid profiles in rat skeletal muscle Exp. Physiol. 94 2009 362 370
107. J.J. Dube et al. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide Diabetologia 54 2011 1147 1156
108. I. Ichi et al. Effect of dietary cholesterol and high fat on ceramide concentration in rat tissues Nutrition 23 2007 570 574 (Pubitemid 47002227)
109. M. Reichel et al. Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients Alcohol. Clin. Exp. Res. 35 2011 1852 1859
110. M. Reichel et al. Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence Alcohol. Clin. Exp. Res. 34 2010 46 50
111. W.E. Whitehead et al. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122 2002 1140 1156 (Pubitemid 34267295)
112. P. Palta et al. Depression and oxidative stress: results from a meta-analysis of observational studies Psychosom. Med. 76 2014 12 19
113. C. Stetler, and G.E. Miller Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research Psychosom. Med. 73 2011 114 126
114. A.H. Kemp et al. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis Biol. Psychiatry 67 2010 1067 1074
115. H. Merrill Jr et al. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins Environ. Health Perspect. 109 Suppl. 2 2001 283 289
116. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572 (Pubitemid 27248754)
117. D.A. Brown, and E. London Functions of lipid rafts in biological membranes Annu. Rev. Cell Dev. Biol. 14 1998 111 136 (Pubitemid 29001451)
118. R.N. Kolesnick et al. Compartmentalization of ceramide signaling: physical foundations and biological effects J. Cell. Physiol. 184 2000 285 300 (Pubitemid 30625491)
119. H. Grassmé et al. Ceramide-rich membrane rafts mediate CD40 clustering J. Immunol. 168 2002 298 307 (Pubitemid 34014130)
120. E. Gulbins, and P.L. Li Physiological and pathophysiological aspects of ceramide Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 R11 R26
121. A. Huwiler et al. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells Biochemistry 37 1998 14556 14562 (Pubitemid 28489064)
122. G. Müller et al. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid EMBO J. 14 1995 1961 1969
123. C.E. Chalfant et al. The structural requirements for ceramide activation of serine-threonine protein phosphatases J. Lipid Res. 45 2004 496 506 (Pubitemid 38337996)
124. Q. Xu et al. The relationship between abdominal obesity and depression in the general population: a systematic review and meta-analysis Obes. Res. Clin. Practice 5 2011 e267 e278